Cannabis Use in People With HIV Linked to Reduced Inflammation and Improved Gut Health
A review found cannabis use in people with HIV is associated with reduced systemic inflammatory markers, improved gut barrier integrity, increased short-chain fatty acid production, and a unique microbiome composition, though effects on HIV reservoirs remain unclear.
Quick Facts
What This Study Found
Cannabis use in PWH was associated with reduced inflammatory biomarkers (MCP-1, IP-10), improved gut barrier integrity through increased SCFA production, increased gut mucosal immunity, decreased immune activation, and a unique microbiome composition. Preliminary evidence suggests cannabis may influence HIV reservoirs, but results are inconclusive.
Key Numbers
Reduced MCP-1 and IP-10 biomarkers. Increased SCFA production. Improved gut barrier integrity. Effects on HIV reservoirs inconclusive.
How They Did This
Narrative review of studies examining cannabis effects on gut microbiome, immune system, and ART outcomes in people with HIV.
Why This Research Matters
Chronic inflammation persists in people with HIV even on effective antiretroviral therapy, contributing to non-AIDS comorbidities. Cannabis may address this through immunomodulatory and gut-protective effects, potentially improving long-term outcomes.
The Bigger Picture
As HIV becomes a chronic manageable condition, addressing persistent inflammation becomes crucial. Cannabis may offer anti-inflammatory benefits without the immunosuppressive risks of conventional anti-inflammatory drugs in this population.
What This Study Doesn't Tell Us
Review format. Most evidence observational. Standardized cannabis formulations not used in studies. ART adherence concerns not fully addressed. Long-term outcomes unknown.
Questions This Raises
- ?Could standardized cannabis formulations be tested in HIV clinical trials?
- ?Does the microbiome change from cannabis use translate to clinical benefit in PWH?
Trust & Context
- Key Stat:
- Cannabis reduced inflammatory biomarkers MCP-1 and IP-10 in PWH
- Evidence Grade:
- Synthesizes multiple lines of evidence with clear conclusions, but primarily observational studies without controlled trials.
- Study Age:
- 2025 review of cannabis-HIV interactions across inflammation, immunity, and microbiome.
- Original Title:
- Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome.
- Published In:
- Current HIV/AIDS reports, 22(1), 19 (2025)
- Authors:
- Langat, Robert, Chakrawarti, Ashma, Klatt, Nichole R(2)
- Database ID:
- RTHC-06892
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Is cannabis beneficial for people with HIV?
This review found cannabis is associated with reduced inflammation and improved gut health in PWH, but effects on HIV reservoirs and ART adherence need more research.
How does cannabis affect the gut in HIV?
Cannabis use was associated with improved gut barrier integrity, increased beneficial short-chain fatty acid production, and a unique microbiome composition in people with HIV.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBD-oil-quality-guide
- CBT-cannabis-recovery
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cannabis-relapse-cycle-pattern
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- medical-benefits-of-cannabis
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-before-surgery
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- seniors-older-adults-cannabis-risks-medications
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-breastfeeding-THC-breast-milk
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-06892APA
Langat, Robert; Chakrawarti, Ashma; Klatt, Nichole R. (2025). Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome.. Current HIV/AIDS reports, 22(1), 19. https://doi.org/10.1007/s11904-025-00729-0
MLA
Langat, Robert, et al. "Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome.." Current HIV/AIDS reports, 2025. https://doi.org/10.1007/s11904-025-00729-0
RethinkTHC
RethinkTHC Research Database. "Cannabis Use in HIV: Impact on Inflammation, Immunity and th..." RTHC-06892. Retrieved from https://rethinkthc.com/research/langat-2025-cannabis-use-in-hiv
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.